{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T15:03:39Z","timestamp":1772463819380,"version":"3.50.1"},"reference-count":57,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2018,12,18]],"date-time":"2018-12-18T00:00:00Z","timestamp":1545091200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010580","name":"Department of Science and Technology, Hubei Provincial People's Government","doi-asserted-by":"publisher","award":["2018ABA107"],"award-info":[{"award-number":["2018ABA107"]}],"id":[{"id":"10.13039\/501100010580","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>Japanese encephalitis is a zoonotic disease caused by the Japanese encephalitis virus (JEV). It is mainly epidemic in Asia with an estimated 69,000 cases occurring per year. However, no approved agents are available for the treatment of JEV infection, and existing vaccines cannot control various types of JEV strains. Drug repurposing is a new concept for finding new indication of existing drugs, and, recently, the concept has been used to discover new antiviral agents. Identifying host proteins involved in the progress of JEV infection and using these proteins as targets are the center of drug repurposing for JEV infection. In this study, based on the gene expression data of JEV infection and the phenome-wide association study (PheWAS) data, we identified 286 genes that participate in the progress of JEV infection using systems biology methods. The enrichment analysis of these genes suggested that the genes identified by our methods were predominantly related to viral infection pathways and immune response-related pathways. We found that bortezomib, which can target these genes, may have an effect on the treatment of JEV infection. Subsequently, we evaluated the antiviral activity of bortezomib using a JEV-infected mouse model. The results showed that bortezomib can lower JEV-induced lethality in mice, alleviate suffering in JEV-infected mice and reduce the damage in brains caused by JEV infection. This work provides an agent with new indication to treat JEV infection.<\/jats:p>","DOI":"10.3390\/molecules23123346","type":"journal-article","created":{"date-parts":[[2018,12,18]],"date-time":"2018-12-18T03:12:30Z","timestamp":1545102750000},"page":"3346","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Drug Repurposing for Japanese Encephalitis Virus Infection by Systems Biology Methods"],"prefix":"10.3390","volume":"23","author":[{"given":"Bo-Min","family":"Lv","sequence":"first","affiliation":[{"name":"Hubei Key Laboratory of Agricultural Bioinformatics, College of Informatics, Huazhong Agricultural University, Wuhan 430070, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin-Yu","family":"Tong","sequence":"additional","affiliation":[{"name":"Hubei Key Laboratory of Agricultural Bioinformatics, College of Informatics, Huazhong Agricultural University, Wuhan 430070, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Quan","sequence":"additional","affiliation":[{"name":"Hubei Key Laboratory of Agricultural Bioinformatics, College of Informatics, Huazhong Agricultural University, Wuhan 430070, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng-Yuan","family":"Liu","sequence":"additional","affiliation":[{"name":"Hubei Key Laboratory of Agricultural Bioinformatics, College of Informatics, Huazhong Agricultural University, Wuhan 430070, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing-Ye","family":"Zhang","sequence":"additional","affiliation":[{"name":"Hubei Key Laboratory of Agricultural Bioinformatics, College of Informatics, Huazhong Agricultural University, Wuhan 430070, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun-Feng","family":"Song","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Agricultural Microbiology, Huazhong Agricultural University, Wuhan 430070, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong-Yu","family":"Zhang","sequence":"additional","affiliation":[{"name":"Hubei Key Laboratory of Agricultural Bioinformatics, College of Informatics, Huazhong Agricultural University, Wuhan 430070, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2018,12,18]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nrneurol.2018.30","article-title":"Japanese encephalitis\u2014The prospects for new treatments","volume":"14","author":"Turtle","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"263","DOI":"10.4161\/hv.26902","article-title":"Japanese encephalitis: The virus and vaccines","volume":"10","author":"Yun","year":"2014","journal-title":"Hum. Vaccin. Immunother."},{"key":"ref_3","first-page":"11","article-title":"Japanese Encephalitis Virus: Ecology and Epidemiology","volume":"267","author":"Endy","year":"2002","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"766","DOI":"10.2471\/BLT.10.085233","article-title":"Estimated global incidence of Japanese encephalitis: A systematic review","volume":"89","author":"Campbell","year":"2015","journal-title":"Bull. World Health Org."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s00508-008-1071-9","article-title":"Japanese encephalitis and vaccines: Past and future prospects","volume":"120","author":"Kollaritsch","year":"2008","journal-title":"Wien. Wochenschr."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/nrd.2016.244","article-title":"Applications of chemogenomic library screening in drug discovery","volume":"16","author":"Jones","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/nm.3595","article-title":"Overcoming drug development bottlenecks with repurposing: Old drugs learn new tricks","volume":"20","author":"Strittmatter","year":"2014","journal-title":"Nat. Med."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Iorio, F., Saez-Rodriguez, J., and Bernardo, D. (2013). Di network based elucidation of drug response: From modulators to targets. BMC Syst. Biol., 7.","DOI":"10.1186\/1752-0509-7-139"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.tim.2018.04.004","article-title":"Drug Repurposing for Viral Infectious Diseases: How Far Are We?","volume":"26","author":"Mercorelli","year":"2018","journal-title":"Trends Microbiol."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Schuler, J., Hudson, M.L., Schwartz, D., and Samudrala, R. (2017). A Systematic Review of Computational Drug Discovery, Development, and Repurposing for Ebola Virus Disease Treatment. Molecules, 22.","DOI":"10.3390\/molecules22101777"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"3851","DOI":"10.1016\/j.bmcl.2017.06.049","article-title":"Discovery of novel dengue virus entry inhibitors via a structure-based approach","volume":"27","author":"Leal","year":"2017","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1080\/07391102.2016.1157037","article-title":"Genetics-directed drug discovery for combating Mycobacterium tuberculosis infection","volume":"35","author":"Quan","year":"2017","journal-title":"J. Biomol. Struct. Dyn."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"952","DOI":"10.2174\/138920012802138633","article-title":"Functional genomics- and network-driven systems biology approaches for pharmacogenomics and toxicogenomics","volume":"13","author":"Yang","year":"2012","journal-title":"Curr. Drug Metabol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/j.drudis.2012.06.015","article-title":"Opportunities in systems biology to discover mechanisms and repurpose drugs for CNS diseases","volume":"17","author":"Mei","year":"2012","journal-title":"Drug Discov. Today"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1186\/1471-2105-6-233","article-title":"GeneRank: Using search engine technology for the analysis of microarray experiments","volume":"21","author":"Morrison","year":"2005","journal-title":"BMC Bioinform."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/ng.3168","article-title":"Pan-cancer network analysis identifies combinations of rare somatic mutations across pathways and protein complexes","volume":"47","author":"Leiserson","year":"2014","journal-title":"Nat. Genet."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"20263","DOI":"10.1038\/srep20263","article-title":"Dynamic changes in global microRNAome and transcriptome reveal complex miRNA-mRNA regulated host response to Japanese encephalitis virus in microglial cells","volume":"6","author":"Kumari","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1002\/jmv.24397","article-title":"Porcine 2\u2032,5\u2032-oligoadenylate synthetases inhibit Japanese encephalitis virus replication in vitro","volume":"88","author":"Zheng","year":"2015","journal-title":"J. Med. Virol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1742-2094-11-24","article-title":"Regulatory role of TRIM21 in the type-I interferon pathway in Japanese encephalitis virus-infected human microglial cells","volume":"11","author":"Manocha","year":"2014","journal-title":"J. Neuroinflamm."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"33698","DOI":"10.1038\/srep33698","article-title":"TRIM52 inhibits Japanese Encephalitis Virus replication by degrading the viral NS2A","volume":"6","author":"Fan","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_21","first-page":"284","article-title":"Clusterprofiler: An R package for comparing biological themes among gene clusters","volume":"16","author":"Yu","year":"2012","journal-title":"Coru\u00f1a J. Integr. Biol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1093\/nar\/gkv1165","article-title":"DGIdb 2.0: Mining clinically relevant drug\u2013gene interactions","volume":"44","author":"Wagner","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1093\/nar\/gkt1129","article-title":"Therapeutic target database update 2014: A resource for targeted therapeutics","volume":"42","author":"Qin","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1093\/nar\/gkt1068","article-title":"DrugBank 4.0: Shedding new light on drug metabolism","volume":"42","author":"Law","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Choy, M.M., Zhang, S.L., Costa, V.V., Tan, H.C., Horrevorts, S., and Ooi, E.E. (2015). Proteasome inhibition suppresses dengue virus egress in antibody dependent infection. PLOS Negl. Trop. Dis., 9.","DOI":"10.1371\/journal.pntd.0004058"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"00554","DOI":"10.1128\/JVI.00554-17","article-title":"Quantitative proteomic analysis of mosquito C6\/36 cells reveals host proteins involved in Zika virus infection","volume":"91","author":"Xin","year":"2017","journal-title":"J. Virol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1099\/0022-1317-83-8-1897","article-title":"Suppression of Japanese encephalitis virus infection by non-steroidal anti-inflammatory drugs","volume":"83","author":"Chen","year":"2002","journal-title":"J. Gen. Virol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1099\/vir.0.18883-0","article-title":"Interference in Japanese encephalitis virus infection of Vero cells by a cationic amphiphilic drug, chlorpromazine","volume":"84","author":"Nawa","year":"2003","journal-title":"J. Gen. Virol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/s11481-009-9158-2","article-title":"Curcumin protects neuronal cells from Japanese encephalitis virus-mediated cell death and also inhibits infective viral particle formation by dysregulation of ubiquitin\u2013proteasome system","volume":"4","author":"Dutta","year":"2009","journal-title":"J. Neuroimmune Pharmacol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1093\/infdis\/jiu179","article-title":"Etanercept reduces neuroinflammation and lethality in mouse model of Japanese encephalitis","volume":"210","author":"Ye","year":"2014","journal-title":"J. Infect. Dis."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.bbrc.2004.12.034","article-title":"Tyrosine kinase inhibitors attenuate Japanese encephalitis virus-induced neurotoxicity","volume":"327","author":"Raung","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1111\/j.1471-4159.2008.05238.x","article-title":"Minocycline neuroprotects, reduces microglial activation, inhibits caspase 3 induction, and viral replication following Japanese encephalitis","volume":"105","author":"Mishra","year":"2008","journal-title":"J. Neurochem."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"16785","DOI":"10.3390\/ijms131216785","article-title":"Antiviral activity of baicalein and quercetin against the Japanese encephalitis virus","volume":"13","author":"Johari","year":"2012","journal-title":"Int. J. Mol. Sci."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.1472-765X.2012.03282.x","article-title":"Combination of N-methylisatin-\u03b2-thiosemicarbazone derivative (SCH16) with ribavirin and mycophenolic acid potentiates the antiviral activity of SCH16 against Japanese encephalitis virus in vitro","volume":"55","author":"Sebastian","year":"2012","journal-title":"Lett. Appl. Microbiol."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Lu, C.Y., Chang, Y.C., Hua, C.H., Chuang, C., Huang, S.H., Kung, S.H., Hour, M.J., and Lin, C.W. (2017). Tubacin, an HDAC6 Selective Inhibitor, Reduces the Replication of the Japanese Encephalitis Virus via the Decrease of Viral RNA Synthesis. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18050954"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1002\/glia.22282","article-title":"Glutamate released by Japanese encephalitis virus-infected microglia involves TNF-\u03b1 signaling and contributes to neuronal death","volume":"60","author":"Chen","year":"2012","journal-title":"Glia"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1086\/596309","article-title":"Randomized, controlled trial of oral ribavirin for Japanese encephalitis in children in Uttar Pradesh, India","volume":"48","author":"Kumar","year":"2009","journal-title":"Clin. Infect. Dis."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s12879-016-1385-6","article-title":"Role of oral Minocycline in acute encephalitis syndrome in India-a randomized controlled trial","volume":"16","author":"Kumar","year":"2015","journal-title":"BMC Infect. Dis."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1038\/ng.3314","article-title":"The support of human genetic evidence for approved drug indications","volume":"47","author":"Nelson","year":"2015","journal-title":"Nat. Genet."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1038\/nbt.2749","article-title":"Systematic comparison of phenome-wide association study of electronic medical record data and genome-wide association study data","volume":"31","author":"Denny","year":"2013","journal-title":"Nat. Biotechnol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.virol.2016.08.013","article-title":"The ubiquitin-proteasome system is essential for the productive entry of Japanese encephalitis virus","volume":"498","author":"Wang","year":"2016","journal-title":"Virology"},{"key":"ref_42","first-page":"2980","article-title":"Appraising the roles of cbll1 and the ubiquitin\/proteasome system for flavivirus entry and replication","volume":"85","author":"Meertens","year":"2010","journal-title":"J. Virol."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Amaya, M., Keck, F., Lindquist, M., Voss, K., Scavone, L., Kehn-Hall, K., Roberts, B., Bailey, C., Schmaljohn, C., and Narayanan, A. (2015). The ubiquitin proteasome system plays a role in venezuelan equine encephalitis virus infection. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0124792"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s12031-012-9783-8","article-title":"Neuroglial Expression of the MHCI Pathway and PirB Receptor Is Upregulated in the Hippocampus with Advanced Aging","volume":"48","author":"Starkey","year":"2012","journal-title":"J. Mol. Neurosci."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"6291","DOI":"10.1128\/JVI.79.10.6291-6298.2005","article-title":"New antiviral pathway that mediates hepatitis c virus replicon interferon sensitivity through adar1","volume":"79","author":"Taylor","year":"2005","journal-title":"J. Virol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1007\/s10620-007-0129-2","article-title":"Interferon beta 1a versus interferon beta 1a plus ribavirin for the treatment of chronic hepatitis c in Chinese patients: A randomized, placebo-controlled trial","volume":"53","author":"Han","year":"2007","journal-title":"Dig. Dis. Sci."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1093\/infdis\/jiv392","article-title":"Treatment with lopinavir\/ritonavir or interferon-\u03b21b improves outcome of MERS-CoV infection in a nonhuman primate model of common marmoset","volume":"212","author":"Chan","year":"2015","journal-title":"J. Infect. Dis."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s00705-014-2302-1","article-title":"Caffeine inhibits hepatitis c virus replication in vitro","volume":"160","author":"Batista","year":"2014","journal-title":"Arch. Virol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/hep.23279","article-title":"Increased caffeine consumption is associated with reduced hepatic fibrosis","volume":"51","author":"Modi","year":"2009","journal-title":"Hepatology"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"e00368-17","DOI":"10.1128\/mBio.00368-17","article-title":"Topoisomerase II Inhibitors Induce DNA Damage-Dependent Interferon Responses Circumventing Ebola Virus Immune Evasion","volume":"8","author":"Luthra","year":"2017","journal-title":"mBio"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1080\/10495398.2016.1232268","article-title":"Antiviral compounds against nucleocapsid protein of porcine epidemic diarrhea virus","volume":"28","author":"Deejai","year":"2016","journal-title":"Anim. Biotechnol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"353","DOI":"10.2146\/ajhp130281","article-title":"Carfilzomib: A second-generation proteasome inhibitor for the treatment of multiple myeloma","volume":"72","author":"Ali","year":"2015","journal-title":"Am. Soc. Health Syst. Pharm."},{"key":"ref_53","first-page":"352","article-title":"A review of deferasirox, bortezomib, dasatinib, and cyclosporine eye drops: Possible uses and known side effects in cutaneous medicine","volume":"6","author":"Scheinfeld","year":"2007","journal-title":"J. Drugs Dermatol."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Das, J., and Yu, H. (2012). Hint: High-quality protein interactomes and their applications in understanding human disease. BMC Syst. Biol., 6.","DOI":"10.1186\/1752-0509-6-92"},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Razick, S., Magklaras, G., and Donaldson, I.M. (2008). Irefindex: A consolidated protein interaction database with provenance. BMC Bioinform., 9.","DOI":"10.1186\/1471-2105-9-405"},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Khurana, E., Fu, Y., Chen, J., and Gerstein, M. (2013). Interpretation of genomic variants using a unified biological network approach. PLoS Comput. Biol., 9.","DOI":"10.1371\/journal.pcbi.1002886"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"D447","DOI":"10.1093\/nar\/gku1003","article-title":"STRING v10: Protein-protein interaction networks, integrated over the tree of life","volume":"43","author":"Szklarczyk","year":"2015","journal-title":"Nucleic Acids Res."}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/23\/12\/3346\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T15:34:38Z","timestamp":1760196878000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/23\/12\/3346"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,18]]},"references-count":57,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["molecules23123346"],"URL":"https:\/\/doi.org\/10.3390\/molecules23123346","relation":{"has-preprint":[{"id-type":"doi","id":"10.20944\/preprints201811.0478.v1","asserted-by":"object"}],"has-review":[{"id-type":"doi","id":"10.3410\/f.734668211.793567018","asserted-by":"object"}]},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,18]]}}}